Fleisher, Carl <br/><br/>
Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder.  [electronic resource] 

 -  Expert opinion on investigational drugs  Aug 2014 
 - 1157-63 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7658 
<br/><br/><label>Standard No.: </label>10.1517/13543784.2014.934806  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Atomoxetine Hydrochloride<br/>Attention Deficit Disorder with Hyperactivity--drug therapy<br/>Azabicyclo Compounds--adverse effects<br/>Humans<br/>Nicotinic Agonists--adverse effects<br/>Propylamines--adverse effects<br/>Pyridines--adverse effects<br/>Receptors, Nicotinic--drug effects